Chrysler
Summary
NHTSA campaign 25V766: Chrysler recalled for a safety defect. A loss of drive power increases the risk of a crash, and a vehicle fire can increase the risk of injury.
Details
Source
nhtsa
External ID
25V766
Action Date
2025-11-06
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2023-2025 Jeep Grand Cherokee 4XE and 2024-2025 Jeep Wrangler 4XE Plug-In Hybrid Electric (PHEV) vehicles. Debris inside the engine may cause engine failure, which can result in a loss of drive power and/or an engine compartment fire.
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle